Clinical Trial Update: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the SYNERGY 48 mm stent system in coronary artery disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• SYNERGY 48 mm Stent System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-02-05